Utility of NICaS Non-Invasive Hemodynamic Monitoring in Critically Ill Patients with COVID-19

Wisam Zabeeda,Jonah Benjamin Cohen,Anat Reiner Benaim,Shiri Zarour,Yael Lichter,Idit Matot,Or Goren
DOI: https://doi.org/10.3390/jcm13072072
IF: 3.9
2024-04-04
Journal of Clinical Medicine
Abstract:(1) Background: COVID-19 presented many challenges to effective treatments, such as managing cardiovascular insufficiency while mitigating risks to healthcare providers. This study utilized NICaS, a non-invasive hemodynamic monitor that provides advanced data via whole-body impedance analysis. We investigated the associated trends in hemodynamic parameters obtained by the NICaS device and their correlation with in-hospital all-cause mortality during COVID-19 hospitalization in the intensive care unit. (2) Methods: Data from 29 patients with COVID-19 admitted to the intensive care unit and monitored with NICaS between April 2020 and February 2021 were analyzed retrospectively. (3) Results: Decreasing cardiac output and cardiac power were significantly associated with death. Total peripheral resistance was significantly increasing in non-survivors as was total body water percentage. Those admitted with a heart rate above 90 beats per minute had a significantly reduced survival. (4) Conclusions: Non-invasive hemodynamic monitoring via the NICaS device is simple and effective in evaluating critically ill patients with COVID-19 and may help guide clinical management via remote monitoring. Controlling tachycardia may help ensure adequate oxygen supply-demand ratio. A hint toward a beneficiary effect of a restrictive fluid balance may be observed.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the trends of hemodynamic parameters using the non - invasive hemodynamic monitoring device NICaS in COVID - 19 critically ill patients and their relationship with all - cause mortality during hospitalization. Specifically, the study aims to: 1. **Explore the application value of the NICaS device in COVID - 19 intensive care unit (ICU) patients**: - The study investigates the changing trends of hemodynamic parameters (such as cardiac output, cardiac power, total peripheral resistance, etc.) obtained by non - invasive methods. - Analyze the relationship between these parameters and all - cause mortality during hospitalization. 2. **Evaluate the potential role of non - invasive monitoring in clinical management**: - Through remote monitoring, reduce the direct contact between medical staff and patients and lower the risk of infection. - Provide real - time hemodynamic data to help doctors better manage patients' conditions. 3. **Explore the impact of specific hemodynamic parameters on patient prognosis**: - For example, whether the changes in parameters such as cardiac index (CI), cardiac power index (CPI), total peripheral resistance index (TPRI) and total body water percentage (TBW) are related to the survival rate of patients. - Pay special attention to whether patients with a heart rate (HR) exceeding 90 beats per minute have a higher risk of death. 4. **Verify the measurement accuracy of the NICaS device**: - By comparison with echocardiography, evaluate the accuracy of the NICaS device in measuring stroke volume index (SI), etc. In summary, the main objective of this study is to evaluate the application effect of the NICaS non - invasive hemodynamic monitoring device in COVID - 19 critically ill patients and the potential impact of these monitoring data on clinical management and patient prognosis.